[Hub]/) : Traits : Ulcerative Colitis (UC) :

chr17:37,083,464-39,502,398

Best TWAS P=3.88e-17 · Best GWAS P=7.18e-18 conditioned to 0.0388

Associated models

# Study Tissue Gene h2 eQTL R2 model # weights model R2 model R2 P eQTL GWAS Z TWAS Z TWAS P Top SNP corr PP3 PP4 joint
1 CommonMind Brain Pre-frontal Cortex CASC3 0.08 0.00 bslmm 319 0.01 1.2e-02 4.28 -6.0 1.7e-09 -0.34 0.13 0.05 FALSE
2 GTEx Adipose Subcutaneous KRT222 0.11 0.09 lasso 4 0.10 1.3e-08 -4.85 5.3 1.5e-07 0.05 0.05 0.95 FALSE
3 GTEx Brain Nucleus accumbens basal ganglia RAPGEFL1 0.16 0.06 lasso 4 0.07 7.7e-03 8.57 8.4 3.9e-17 0.87 0.02 0.87 TRUE
4 GTEx Breast Mammary Tissue ORMDL3 0.17 0.04 enet 27 0.06 7.2e-04 6.77 6.3 2.9e-10 0.78 0.03 0.94 FALSE
5 GTEx Colon Transverse GSDMB 0.14 0.11 enet 18 0.12 2.0e-06 8.02 -7.1 9.7e-13 -0.91 0.16 0.84 FALSE
6 GTEx Esophagus Mucosa GSDMB 0.06 0.04 lasso 3 0.03 4.7e-03 -5.58 -6.4 1.8e-10 -0.69 0.16 0.39 FALSE
7 GTEx Esophagus Mucosa ORMDL3 0.09 0.01 enet 20 0.00 1.8e-01 -5.04 -5.7 9.1e-09 -0.53 0.10 0.15 FALSE
8 GTEx Esophagus Mucosa KRT222 0.18 0.12 enet 8 0.12 1.1e-08 -5.38 5.1 2.9e-07 0.07 0.01 0.99 FALSE
9 GTEx Heart Atrial Appendage PPP1R1B 0.09 0.04 enet 10 0.08 2.2e-04 -5.30 -5.7 1.3e-08 -0.74 0.18 0.68 FALSE
10 GTEx Heart Atrial Appendage ERBB2 0.13 0.04 enet 18 0.02 4.8e-02 -3.54 -5.5 4.1e-08 -0.66 0.11 0.60 FALSE
11 GTEx Heart Atrial Appendage PNMT 0.14 -0.01 lasso 8 0.00 5.3e-01 8.57 -7.6 3.2e-14 -0.85 0.03 0.87 FALSE
12 GTEx Liver PGAP3 0.27 0.17 lasso 4 0.13 1.7e-04 -4.44 -5.4 7.1e-08 -0.59 0.31 0.57 FALSE
13 GTEx Lung GSDMB 0.07 0.07 lasso 4 0.05 1.5e-04 -5.77 -5.3 1.2e-07 -0.81 0.44 0.28 FALSE
14 GTEx Lung CASC3 0.10 0.00 enet 47 0.02 2.2e-02 1.48 -5.3 1.4e-07 -0.35 0.05 0.41 FALSE
15 GTEx Pancreas PGAP3 0.37 0.25 lasso 6 0.21 1.9e-09 -4.44 -5.3 1.0e-07 -0.61 0.43 0.57 FALSE
16 GTEx Prostate PGAP3 0.23 0.03 enet 26 0.06 1.6e-02 -3.60 -5.2 2.1e-07 -0.53 0.14 0.41 FALSE
17 GTEx Skin Sun Exposed Lower leg ERBB2 0.10 0.01 enet 8 0.01 3.5e-02 -4.42 -6.7 1.9e-11 -0.77 0.04 0.89 FALSE
18 GTEx Spleen GSDMB 0.50 0.45 enet 14 0.43 1.9e-12 -5.86 -6.3 3.0e-10 -0.87 0.69 0.31 FALSE
19 GTEx Spleen ORMDL3 0.40 0.44 enet 11 0.39 5.7e-11 -5.86 -6.5 5.8e-11 -0.88 0.64 0.36 FALSE
20 GTEx Thyroid PGAP3 0.19 0.21 lasso 10 0.24 3.5e-18 -4.68 -5.5 4.0e-08 -0.61 1.00 0.00 FALSE
21 GTEx Whole Blood GSDMB 0.15 0.10 lasso 4 0.10 4.5e-09 -7.48 -7.6 2.8e-14 -0.94 0.22 0.78 FALSE
22 GTEx Whole Blood ORMDL3 0.18 0.12 lasso 5 0.14 1.8e-12 -5.77 -6.9 4.9e-12 -0.93 0.07 0.93 FALSE
23 METSIM Adipose GSDMA 0.14 0.16 lasso 7 0.17 2.6e-24 -5.58 6.2 7.5e-10 0.60 1.00 0.00 FALSE
24 METSIM Adipose RP11-387H17.4 0.04 0.00 bslmm 286 0.01 8.4e-03 -0.28 5.8 7.1e-09 0.71 0.03 0.67 FALSE
25 NTR Blood GSDMB 0.09 0.10 enet 16 0.12 3.8e-36 -7.37 -7.0 2.1e-12 -0.88 0.65 0.35 FALSE
26 NTR Blood IKZF3 0.04 0.03 blup 319 0.02 1.5e-08 8.54 6.9 6.3e-12 0.89 0.01 0.99 FALSE
27 NTR Blood ORMDL3 0.10 0.10 enet 24 0.12 4.4e-36 8.52 -6.9 5.7e-12 -0.91 0.01 0.99 FALSE
28 NTR Blood SMARCE1 0.04 0.03 lasso 4 0.04 6.5e-13 -5.38 -5.2 2.1e-07 -0.06 0.01 0.99 FALSE
29 YFS Blood GSDMB 0.36 0.41 lasso 12 0.49 4.0e-186 -7.54 -6.8 1.0e-11 -0.91 0.95 0.05 FALSE
30 YFS Blood ORMDL3 0.31 0.36 lasso 9 0.45 2.2e-165 -7.54 -6.7 2.3e-11 -0.88 0.96 0.04 FALSE
31 The Cancer Genome Atlas Bladder Urothelial Carcinoma GSDMA 0.05 0.06 lasso 4 0.05 7.8e-05 -6.01 6.1 1.2e-09 0.54 0.20 0.27 FALSE
32 The Cancer Genome Atlas Breast Invasive Carcinoma GSDMA 0.61 0.49 lasso 5 0.51 5.0e-124 -6.01 5.8 7.5e-09 0.50 0.98 0.02 FALSE
33 The Cancer Genome Atlas Colon Adenocarcinoma GSDMB 0.10 0.15 blup 40 0.14 1.2e-08 8.61 -7.2 4.9e-13 -0.95 0.01 0.99 FALSE
34 The Cancer Genome Atlas Glioblastoma Multiforme GSDMA 0.58 0.33 enet 10 0.34 5.3e-11 -6.01 5.4 6.6e-08 0.47 0.97 0.02 FALSE
35 The Cancer Genome Atlas Head and Neck Squamous Cell Carcinoma KRT222 0.02 0.01 lasso 5 0.01 6.8e-02 -4.84 5.3 1.3e-07 0.03 0.01 0.81 FALSE
36 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma GSDMA 0.66 0.48 enet 21 0.51 1.2e-65 -6.01 5.7 1.5e-08 0.49 0.98 0.02 FALSE
37 The Cancer Genome Atlas Kidney Renal Clear Cell Carcinoma ORMDL3 0.01 0.01 blup 36 0.00 8.5e-02 8.61 -7.2 7.4e-13 -0.94 0.01 0.83 FALSE
38 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma GSDMA 0.37 0.44 lasso 1 0.44 3.3e-27 -6.01 6.0 1.8e-09 0.50 0.98 0.02 FALSE
39 The Cancer Genome Atlas Kidney Renal Papillary Cell Carcinoma PGAP3 0.16 0.16 enet 14 0.15 5.1e-09 -4.44 -5.4 8.3e-08 -0.49 0.02 0.97 FALSE
40 The Cancer Genome Atlas Brain Lower Grade Glioma C17orf37 0.04 0.01 enet 3 0.01 2.3e-02 -2.91 6.3 3.2e-10 0.62 0.01 0.50 FALSE
41 The Cancer Genome Atlas Brain Lower Grade Glioma GSDMA 0.65 0.56 lasso 4 0.58 1.5e-81 -6.01 5.7 9.2e-09 0.49 0.98 0.02 FALSE
42 The Cancer Genome Atlas Brain Lower Grade Glioma GSDMB 0.06 0.05 enet 7 0.05 2.2e-06 -5.88 -6.1 8.0e-10 -0.87 0.47 0.50 FALSE
43 The Cancer Genome Atlas Liver Hepatocellular Carcinoma GSDMA 0.41 0.37 lasso 2 0.38 3.7e-19 -6.01 6.1 1.3e-09 0.54 0.98 0.02 FALSE
44 The Cancer Genome Atlas Lung Adenocarcinoma GSDMA 0.30 0.35 lasso 4 0.35 6.3e-43 -6.01 5.9 3.9e-09 0.46 0.98 0.02 FALSE
45 The Cancer Genome Atlas Lung Adenocarcinoma GSDMB 0.05 0.07 blup 39 0.05 1.4e-06 -5.81 -6.3 3.0e-10 -0.86 0.50 0.50 FALSE
46 The Cancer Genome Atlas Lung Squamous Cell Carcinoma GSDMA 0.15 0.19 enet 9 0.19 1.7e-21 -6.01 6.2 4.9e-10 0.55 0.98 0.02 FALSE
47 The Cancer Genome Atlas Lung Squamous Cell Carcinoma GSDMB 0.02 0.01 blup 39 0.01 1.5e-02 -5.81 -7.3 2.0e-13 -0.97 0.02 0.81 FALSE
48 The Cancer Genome Atlas Lung Squamous Cell Carcinoma ORMDL3 0.03 0.04 lasso 2 0.04 2.9e-05 8.15 -7.2 4.9e-13 -0.96 0.04 0.95 FALSE
49 The Cancer Genome Atlas Ovarian Serous Cystadenocarcinoma GSDMA 0.50 0.37 enet 15 0.43 4.2e-31 -6.01 5.4 8.4e-08 0.45 0.98 0.02 FALSE
50 The Cancer Genome Atlas Pancreatic Adenocarcinoma GSDMA 0.23 0.29 enet 6 0.24 2.8e-10 -6.01 6.0 2.1e-09 0.49 0.96 0.04 FALSE
51 The Cancer Genome Atlas Pancreatic Adenocarcinoma GSDMB 0.14 0.16 lasso 4 0.14 2.4e-06 8.52 -7.7 1.0e-14 -0.99 0.00 1.00 FALSE
52 The Cancer Genome Atlas Pancreatic Adenocarcinoma SMARCE1 0.13 0.11 lasso 4 0.11 2.6e-05 -5.38 -5.6 2.6e-08 -0.05 0.01 0.99 TRUE
53 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma GSDMA 0.52 0.34 lasso 4 0.36 5.1e-15 -6.01 5.4 5.5e-08 0.46 0.98 0.02 FALSE
54 The Cancer Genome Atlas Pheochromocytoma and Paraganglioma PGAP3 0.17 0.13 blup 41 0.10 6.8e-05 -4.79 -5.2 1.9e-07 -0.58 0.01 0.97 FALSE
55 The Cancer Genome Atlas Prostate Adenocarcinoma GSDMA 0.16 0.12 lasso 2 0.12 1.1e-12 -6.01 5.7 9.2e-09 0.48 0.98 0.02 FALSE
56 The Cancer Genome Atlas Prostate Adenocarcinoma KRT222 0.06 0.04 enet 7 0.06 9.7e-07 -4.85 5.3 1.5e-07 0.06 0.02 0.98 FALSE
57 The Cancer Genome Atlas Rectum Adenocarcinoma GSDMB 0.14 0.09 blup 39 0.17 7.0e-05 7.57 -7.4 1.2e-13 -0.93 0.02 0.91 FALSE
58 The Cancer Genome Atlas Soft Tissue Sarcoma GSDMA 0.44 0.45 lasso 4 0.44 3.2e-28 -6.01 6.1 9.9e-10 0.51 0.98 0.02 FALSE
59 The Cancer Genome Atlas Skin Cutaneous Melanoma GSDMA 0.23 0.16 blup 47 0.18 1.3e-05 -6.01 6.3 2.7e-10 0.61 0.02 0.91 FALSE
60 The Cancer Genome Atlas Stomach Adenocarcinoma GSDMB 0.06 0.08 enet 7 0.08 1.1e-06 -5.82 -7.2 7.1e-13 -0.95 0.03 0.97 FALSE
61 The Cancer Genome Atlas Stomach Adenocarcinoma ZPBP2 0.08 0.09 enet 5 0.10 6.1e-08 -7.22 6.2 4.2e-10 0.89 0.46 0.54 FALSE
62 The Cancer Genome Atlas Testicular Germ Cell Tumors GSDMA 0.38 0.32 enet 7 0.32 5.9e-12 -6.01 5.6 2.0e-08 0.50 0.98 0.02 FALSE
63 The Cancer Genome Atlas Thyroid Carcinoma GSDMA 0.19 0.21 lasso 4 0.24 5.5e-23 -6.01 5.8 6.3e-09 0.54 0.98 0.02 FALSE
64 The Cancer Genome Atlas Thyroid Carcinoma GSDMB 0.08 0.08 blup 40 0.09 6.6e-09 -5.88 -7.0 2.6e-12 -0.84 0.10 0.90 FALSE
65 The Cancer Genome Atlas Thyroid Carcinoma ORMDL3 0.08 0.13 blup 37 0.15 3.8e-14 -5.77 -7.0 1.9e-12 -0.90 0.66 0.34 FALSE